These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12153542)

  • 1. Comparison of neuronal density and subfield sizes in the hippocampus of CD95L-deficient (gld), CD95-deficient (lpr) and nondeficient mice.
    Kovac AD; Grammig J; Mahlo J; Steiner B; Roth K; Nitsch R; Bechmann I
    Eur J Neurosci; 2002 Jul; 16(1):159-63. PubMed ID: 12153542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1).
    Zuliani C; Kleber S; Klussmann S; Wenger T; Kenzelmann M; Schreglmann N; Martinez A; del Rio JA; Soriano E; Vodrazka P; Kuner R; Groene HJ; Herr I; Krammer PH; Martin-Villalba A
    Cell Death Differ; 2006 Jan; 13(1):31-40. PubMed ID: 16003386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for multiple CD95-CD95 ligand interactions in anteriorchamber-associated immune deviation induced by soluble protein antigen.
    Kezuka T; Streilein JW
    Immunology; 2000 Mar; 99(3):451-7. PubMed ID: 10712676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo.
    Do Y; Ryu S; Nagarkatti M; Nagarkatti PS
    Toxicol Sci; 2002 Nov; 70(1):63-72. PubMed ID: 12388836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas- or FasL-deficient mice display an increased sensitivity to nitrobenzene-induced testicular germ cell apoptosis.
    Richburg JH; Nañez A
    Toxicol Lett; 2003 Mar; 139(1):1-10. PubMed ID: 12595153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis.
    Fecho K; Bentley SA; Cohen PL
    Cell Immunol; 1998 Aug; 188(1):19-32. PubMed ID: 9743554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
    Fecho K; Cohen PL
    J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
    Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
    J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis.
    Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS
    Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: characterization of an in vitro system.
    Schlosser SF; Azzaroli F; Dao T; Hingorani R; Crispe IN; Boyer JL
    Hepatology; 2000 Oct; 32(4 Pt 1):779-85. PubMed ID: 11003622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.
    Aragane Y; Kulms D; Metze D; Wilkes G; Pöppelmann B; Luger TA; Schwarz T
    J Cell Biol; 1998 Jan; 140(1):171-82. PubMed ID: 9425165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
    Shimizu M; Fontana A; Takeda Y; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jan; 207(1):41-8. PubMed ID: 11161452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
    Pohl U; Wagenknecht B; Naumann U; Weller M
    Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity.
    Conceição-Silva F; Hahne M; Schröter M; Louis J; Tschopp J
    Eur J Immunol; 1998 Jan; 28(1):237-45. PubMed ID: 9485203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke.
    Martin-Villalba A; Hahne M; Kleber S; Vogel J; Falk W; Schenkel J; Krammer PH
    Cell Death Differ; 2001 Jul; 8(7):679-86. PubMed ID: 11464212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CD95 (APO-1/Fas) and CD95-ligand (CD95L). Implications of these apoptosis mediating receptor/ligand systems in the pathogenesis of autoimmune diseases].
    Möller P; von Reyher U; Leithäuser F; Sträter J
    Verh Dtsch Ges Pathol; 1996; 80():12-20. PubMed ID: 9064994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte-induced T cell elimination is CD95 ligand dependent.
    Bechmann I; Steiner B; Gimsa U; Mor G; Wolf S; Beyer M; Nitsch R; Zipp F
    J Neuroimmunol; 2002 Nov; 132(1-2):60-5. PubMed ID: 12417434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity.
    Kamath AB; Camacho I; Nagarkatti PS; Nagarkatti M
    Toxicol Appl Pharmacol; 1999 Oct; 160(2):141-55. PubMed ID: 10527913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Castration induces apoptosis in the male accessory sex organs of Fas-deficient lpr and Fas ligand-deficient gld mutant mice.
    Sugihara A; Yamada N; Tsujimura T; Iwasaki T; Yamashita K; Takagi Y; Tsuji M; Terada N
    In Vivo; 2001; 15(5):385-90. PubMed ID: 11695234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
    Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
    Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.